High-dose glycine impairs the prepulse inhibition measure of sensorimotor gating in humans (Q48135115)

9 February 2018

title

High-dose glycine impairs the prepulse inhibition measure of sensorimotor gating in humans (English)

1 reference

9 February 2018

author name string

B V O'Neill

1

1 reference

9 February 2018

R J Croft

2

1 reference

9 February 2018

C Mann

3

1 reference

9 February 2018

O Dang

4

1 reference

9 February 2018

S Leung

5

1 reference

9 February 2018

M P Galloway

6

1 reference

9 February 2018

K L Phan

7

1 reference

9 February 2018

P J Nathan

8

1 reference

9 February 2018

language of work or name

English

0 references

publication date

8 July 2010

1 reference

9 February 2018

Journal of Psychopharmacology

published in

1 reference

9 February 2018

volume

25

1 reference

9 February 2018

issue

12

1 reference

9 February 2018

page(s)

1632-1638

1 reference

9 February 2018

Low dose ketamine increases prepulse inhibition in healthy men.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Genetic influences on prepulse inhibition of startle reflex in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Modulation of N-methyl-D-aspartate receptor function by glycine transport

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Committee report: Guidelines for human startle eyeblink electromyographic studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Sensorimotor gating and schizophrenia. Human and animal model studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Glycine tranporter-1 blockade potentiates NMDA-mediated responses in rat prefrontal cortical neurons in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Haloperidol differentially modulates prepulse inhibition and p50 suppression in healthy humans stratified for low and high gating levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Localization of the GLYT1 glycine transporter at glutamatergic synapses in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

The effects of smoking on acoustic prepulse inhibition in healthy men and women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Effects of smoking on acoustic startle and prepulse inhibition in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Clinical and sensorimotor gating effects of ketamine in normals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Beneficial effects of glycine (bioglycin) on memory and attention in young and middle-aged adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Startle response models of sensorimotor gating and habituation deficits in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Caffeine modulates P50 auditory sensory gating in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

The emerging role of glutamate in the pathophysiology and treatment of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Gender differences in prepulse inhibition (PPI) in bipolar disorder: men have reduced PPI, women have increased PPI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Presidential Address, 1974. The more or less startling effects of weak prestimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

The effect of neuroleptic medication on prepulse inhibition in schizophrenia patients: current status and future issues

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Glutamatergic neurotransmission modulators as emerging new drugs for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

High glycine levels are associated with prepulse inhibition deficits in chronic schizophrenia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Effects of phencyclidine on prepulse inhibition of acoustic startle response in the macaque

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Recent advances in the phencyclidine model of schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Amelioration of negative symptoms in schizophrenia by glycine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Glycine and D: -serine, but not D: -cycloserine, attenuate prepulse inhibition deficits induced by NMDA receptor antagonist MK-801.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

An allosteric interaction between the NMDA receptor polyamine and ifenprodil sites in rat cultured cortical neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Prefrontal cortex regulates inhibition and excitation in distributed neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Role of the strychnine-insensitive glycine binding site in the nucleus accumbens and anterodorsal striatum in sensorimotor gating: a behavioral and microdialysis study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Effects of typical and atypical antipsychotics on prepulse inhibition in schizophrenia: a critical evaluation of current evidence and directions for future research

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Human and animal studies of schizophrenia-related gating deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Differential effects of acute serotonin and dopamine depletion on prepulse inhibition and p50 suppression measures of sensorimotor and sensory gating in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Effects of phencyclidine and phencyclidine biologs on sensorimotor gating in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Parametric determinants in pre-stimulus modification of acoustic startle: interaction with ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Glycine binding primes NMDA receptor internalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Glutamate receptor dysfunction and schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Effects of typical and atypical antipsychotics on the prepulse inhibition of the startle reflex in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Increased sensitization of acoustic startle response in spasmodic mice with a mutation of the glycine receptor alpha1-subunit gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

The dopamine D(3) receptor Ser9Gly polymorphism modulates prepulse inhibition of the acoustic startle reflex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Prepulse inhibition of the startle reflex depends on the catechol O-methyltransferase Val158Met gene polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Therapeutic trial with glycine in myoclonus

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

The effects of low dose ketamine on sensory gating, neuroendocrine secretion and behavior in healthy human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

A hyperglycinergic rat model for the pathogenesis of schizophrenia: preliminary findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

Allosteric modulation of NMDA receptor via elevation of brain glycine and D-serine: the therapeutic potentials for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0269881110372546

21 January 2018

Identifiers

DOI

10.1177/0269881110372546

1 reference

9 February 2018

1 reference

9 February 2018